1. 2019
  2. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    ODYSSEY OUTCOMES Committees and Investigators, Aug 2019, In: The Lancet Diabetes and Endocrinology. 7, 8, p. 618-628 11 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2018
  4. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    ODYSSEY OUTCOMES Committees and Investigators & Гуревич, В. С., 29 Nov 2018, In: New England Journal of Medicine. 379, 22, p. 2097-2107 11 p.

    Research output: Contribution to journal › Article › peer-review

  5. Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397

    Espinoza, S., Leo, D., Sotnikova, T. D., Shahid, M., Kääriäinen, T. M. & Gainetdinov, R. R., 21 Jun 2018, In: Frontiers in Pharmacology. 9, JUN, p. 645 11 p., 645.

    Research output: Contribution to journal › Article

  6. PRONOUNCED HYPERACTIVITY, COGNITIVE DYSFUNCTIONS AND BDNF DYSREGULATION IN DOPAMINE TRANSPORTER KNOCKOUT RATS

    Leo, D., Sukhanov, I., Zoratto, F., Illiano, P., Caffino, L., Sanna, F., Messa, G., Emanuele, M., Esposito, A., Dorofeikova, M., Budygin, E. A., Mus, L., Efimova, E. E., Niello, M., Espinoza, S., Sotnikova, T. D., Hoener, M. C., Laviola, G., Fumagalli, F., Adriani, W. & 1 others, Gainetdinov, R. R., 2018, In: Journal of Neuroscience. 38, 8, p. 1959-1972 14 p.

    Research output: Contribution to journal › Article › peer-review

  7. 2017
  8. Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome

    Illiano, P., Bass, C. E., Fichera, L., Mus, L., Budygin, E. A., Sotnikova, T. D., Leo, D., Espinoza, S. & Gainetdinov, R. R., 18 Apr 2017, In: Scientific Reports. 7, 46280.

    Research output: Contribution to journal › Article › peer-review

  9. 2016
  10. Dopamine transporter mutant animals: a translational perspective

    Efimova, EV., Gainetdinov, RR., Budygin, EA. & Sotnikova, TD., 2016, In: Journal of Neurogenetics.

    Research output: Contribution to journal › Literature review

  11. Increased context-dependent conditioning to amphetamine in mice lacking TAAR1.

    Sukhanov, I., Caffino, L., Efimova, EV., Espinoza, S., Sotnikova, TD., Cervo, L., Fumagalli, F. & Gainetdinov, RR., 2016, In: Pharmacological Research.

    Research output: Contribution to journal › Article

  12. 2015
  13. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function

    Espinoza, S., Lignani, G., Caffino, L., Maggi, S., Sukhanov, I., Leo, D., Mus, L., Emanuele, M., Ronzitti, G., Harmeier, A., Medrihan, L., Sotnikova, T. D., Chieregatti, E., Hoener, M. C., Benfenati, F., Tucci, V., Fumagalli, F. & Gainetdinov, R. R., 16 Aug 2015, In: Neuropsychopharmacology. 40, 9, p. 2217-2227 11 p.

    Research output: Contribution to journal › Article › peer-review

  14. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

    Espinoza, S., Ghisi, V., Emanuele, M., Leo, D., Sukhanov, I., Sotnikova, T. D., Chieregatti, E. & Gainetdinov, R. R., Jun 2015, In: Neuropharmacology. 93, p. 308-313 6 p.

    Research output: Contribution to journal › Article › peer-review

  15. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits

    Masoud, S. T., Vecchio, L. M., Bergeron, Y., Hossain, M. M., Nguyen, L. T., Bermejo, M. K., Kile, B., Sotnikova, T. D., Siesser, W. B., Gainetdinov, R. R., Wightman, R. M., Caron, M. G., Richardson, J. R., Miller, G. W., Ramsey, A. J., Cyr, M. & Salahpour, A., 1 Feb 2015, In: Neurobiology of Disease. 74, p. 66-75 10 p.

    Research output: Contribution to journal › Article › peer-review

ID: 181170